We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Marc Bjurlin

Marc A. Bjurlin DO, MSc

Associate Professor and Director of Clinical Trials, Department of Urology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina

Dr. Marc Bjurlin is an Associate Professor of Urology and Director of Clinical Trials at the University of North Carolina at Chapel Hill. He completed resident at Cook County Hospital in Chicago. After residency, Dr Bjurlin completed a fellowship in urologic oncology at New York University along with a master of science degree in clinical investigation through the New York University School of Medicine. Prior to joining UNC, Dr. Bjurlin was Assistant Professor of Urology and Director of Urologic Oncology at NYU Langone Hospital Brooklyn. His research interests include the molecular epidemiology of smoking and e-cigarette use related bladder cancers.

Disclosures

Dr. Bjurlin has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Clinical Features of Cyclophosphamide-Associated Bladder Cancer